ABCL
Price
$4.30
Change
-$0.05 (-1.15%)
Updated
Aug 28 closing price
Capitalization
1.3B
74 days until earnings call
PRAX
Price
$45.27
Change
-$0.72 (-1.57%)
Updated
Aug 29, 02:20 PM (EDT)
Capitalization
967.9M
68 days until earnings call
Interact to see
Advertisement

ABCL vs PRAX

Header iconABCL vs PRAX Comparison
Open Charts ABCL vs PRAXBanner chart's image
AbCellera Biologics
Price$4.30
Change-$0.05 (-1.15%)
Volume$2.47M
Capitalization1.3B
Praxis Precision Medicines
Price$45.27
Change-$0.72 (-1.57%)
Volume$200
Capitalization967.9M
ABCL vs PRAX Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PRAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ABCL: $4.30 vs. PRAX: $45.99)
Brand notoriety: ABCL and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 41% vs. PRAX: 41%
Market capitalization -- ABCL: $1.3B vs. PRAX: $967.9M
ABCL [@Biotechnology] is valued at $1.3B. PRAX’s [@Biotechnology] market capitalization is $967.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 4 bearish.
  • PRAX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than PRAX.

Price Growth

ABCL (@Biotechnology) experienced а 0.00% price change this week, while PRAX (@Biotechnology) price change was -0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

PRAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.3B) has a higher market cap than PRAX($968M). ABCL YTD gains are higher at: 46.758 vs. PRAX (-40.242). ABCL has higher annual earnings (EBITDA): -197.92M vs. PRAX (-271.35M). ABCL has more cash in the bank: 553M vs. PRAX (301M). PRAX has less debt than ABCL: PRAX (755K) vs ABCL (142M). ABCL has higher revenues than PRAX: ABCL (32.9M) vs PRAX (7.77M).
ABCLPRAXABCL / PRAX
Capitalization1.3B968M134%
EBITDA-197.92M-271.35M73%
Gain YTD46.758-40.242-116%
P/E RatioN/AN/A-
Revenue32.9M7.77M424%
Total Cash553M301M184%
Total Debt142M755K18,808%
TECHNICAL ANALYSIS
Technical Analysis
ABCLPRAX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIIEX26.34N/A
N/A
Brandes International Equity I
VSMIX27.72N/A
N/A
Invesco Small Cap Value Y
WAGOX4.35N/A
N/A
Wasatch Global Opportunities Investor
PDEZX19.55N/A
N/A
PGIM Jennison Emerging Markets Eq Opps Z
NWAKX23.69N/A
N/A
Nationwide Janus Henderson Ovrs InsSvc

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.15%
RXRX - ABCL
58%
Loosely correlated
-0.51%
CRSP - ABCL
56%
Loosely correlated
-0.90%
VCYT - ABCL
56%
Loosely correlated
+4.68%
ABSI - ABCL
53%
Loosely correlated
-3.14%
BEAM - ABCL
53%
Loosely correlated
-0.06%
More